Complete response of anaplastic pancreatic carcinoma to paclitaxel treatment selected by chemosensitivity testing
Takeru Wakatsuki, Hiromasa Ohira(Fukushima Medical University), Katsutoshi Obara(Fukushima Medical University Hospital), Masaki Satō(Fukushima Medical University), Goro Shibukawa(Fukushima Medical University), Takuto Hikichi(Fukushima Medical University Hospital), Ai Sato(Fukushima Medical University), Atsushi Irisawa(Dokkyo Medical University), Hidemichi Imamura(Fukushima Medical University), Yuta Takahashi(Kagawa Prefectural Central Hospital), Tsunehiko Ikeda(Fukushima Medical University), Tadayuki Takagi(Fukushima Medical University), Rei Suzuki(The University of Texas MD Anderson Cancer Center), Masanori Terashima(Shizuoka Cancer Center)
Cited by 45
Related Papers
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Short‐term outcomes of multicenter prospective cohort study of gastric endoscopic resection: ‘Real‐world evidence’ in Japan
|Digestive Endoscopy|2018|181
Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST-J score
|Gut|2020|164
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study
|Hepatology Research|2008|143
International consensus statements for endoscopic management of distal biliary stricture
|Journal of Gastroenterology and Hepatology|2019|137